MSLN and neoplasm: Particularly, since all T cells express the Msln-specific TCR in TRex mice, experiments to further engineer the T cells to overcome the suppressive tumor microenvironment by expressing chimeric costimulatory proteins, cytokines or performing genetic screens are now readily feasible.